Mentice Ab · OMXSTO:MNTC
Mentice Ab — Investor Presentation (May 2022)
28 slides from Mentice Ab's investor presentation, May 2022
Slide 1: Company Presentation, May 2022 incl Q1 2022 Results
2 mentice Company Presentation May 2022, incl QI 2022 Results
Slide 2: Disclaimer
Disclaimer mentice IMPORTANT: You must read the following before continuing The following applies to this document, the oral presentation of the information in this document by Mentice AB (the “Company’) or any person on behalf of the Company, and any question-and-answer session that follows the ora
Slide 3: Table of contents
Table of contents smentice @ Introduction to Mentice e Market overview and the medical challenges we are helping solve - @ 4) Status update of QI 2022 «
Slide 4: Mentice in Brief
Mentice in Brief mentice » Mentice AB (‘Mentice’ or the Company’) is a global leading * Large opportunity within the rapidly growing interventional field provider of performance and training solutions for image guided with transition from open to minimal invasive interventional therapies * Solid fun
Slide 5: Table of contents
Table of contents smentice 9 0 Cn O 1 © . 3
Slide 6: What is an Image Guided Interventional Therapy?
Whatis an Image Guided Interventional Therapy? A rapid transition from open surgery to IGIT The clinical environment ' Cath Lab - Operating Room The high-fidelity virtual environmen Physician are navigating clinical devices through the vascular tree using X-ray for guiding The clinical devices are v
Slide 7: The problem of clinical diseases at the core of Mentice's mission
The problem of clinical diseases at the core of Mentice’s mission « mentice Image-guided interventional therapies (IGIT): the art of optimizing the bodies blood vessels and internal organs to their intended form and function * Occluded vessels blocked by placque or clots * Expanded blood vessel Anue
Slide 8: Several key challenges in global healthcare
Several key challenges in global healthcare re Key challenges in global healthcare Several trends showing high demand for simulation tools . . . Deaths per 100k ulation Rapidly aging population Pe pop’ Rising healthcare costs Ischaemic heart disease Rising labor costs & staff shortages Alzheimer dis
Slide 9: Strong underlying market growth driven by solid fundamentals
Strong underlying market growth driven by solid fundamentals = mentice Solid fundamentals market drivers @ Increasing healthcare costs creates need for medical simulation * Medical simulation facilitates increased task proficiency and patient safety * Arapidly aging population with longer life expec
Slide 10: Table of contents
Table of contents smentice o Introduction to Mentice e Market overview and the medical challenges we are helping solve e I 3 4) Status update of QI 2022 «
Slide 11: Our Solutions
Our Solutions * mentice Image Guided Physical flow Cloud-based R&D Consultancy Angiography & Interventional replication systems software app Services robotic integrated simulators solutions systems g ™ SS é cy 4g RIGHT HEART VIST® G7 AND G7+ unique patent protected haptics with a compressive support
Slide 12: How our customers adopt our solutions
How our customers adopt our solutions (enavied video links) =: mentice Operating room integration to re-create the “Virtual Patient flight simulator” in our market. In the videos you will see how Physicians are adopting our solutions to ensure patients get the most efficient treatment and ultimately
Slide 13: Business areas: Customers
Medical Device Industry Healthcare Systems Business areas: Customers Global providers of MedTech devices. The business area includes solutions for training, sales and marketing, research and clinical evaluation. Overarching objectives is to assist our clients in their strive to bring new products sa
Slide 14: Mentice has a top-tier client base
Mentice has a top-tier client base #mentice Key university teaching hospital clients Us * Over 500 hospitals and teaching programs worldwide * Over 2,000 systems delivered to medical device clients . currently as clients * As the hospital / academic institution industry continues to n~ * Strong clie
Slide 15: Business operations and revenue streams
Business operations and revenue streams Mentice is in a transition period from a Perpetual software model into an Annual Recuring Revenue model. Today 61% is generate from Software, Rental and Services NeCouee Jan-March 2022 Jan-March 2021 Full year business segment TSEK 2021 System sales, CAPEX 22,
Slide 16: Go-to-market strategy
Go-to-market strategy Direct sales Tj Abbott Medtronic © BI ]ONIK —_Gusrbet * Mentice direct relation with clients in both the hospital and medical device arena . For medical device the Company is customizing solutions based on their specific demand paris — FRB astazenece? — MicroPort Aésdciog ——_Sc
Slide 17: The expanding solution portfolio with clear ambition
The expanding solution portfolio with clear ambition Illustration of Mentice’s journey i Provide procedural , decision support for Plan & rehearse patient physician guidance Collaborate with teams — Specific Reach proficiency & refine processes Procedures | using objective PREDICTIVE Acquire core -
Slide 18: Financial overview
Financial overview mentice Sales CAGR: +14.3% - 20% L 15% » Mentice has been growing at a high pace during the last 8 years with a sales CAGR of 14.3% during 2014-2021, totalling SEK 185m in 2021 L 10% L 5% » Mentice has turned around to a positive EBIT margin in 2021 (+1%) after a decrease during 2
Slide 19: Why invest in Mentice?
Why invest in Mentice? mentice @ Global leader in advanced image guided interventional therapies and training solutions 5 Proven business model with strong operational leverage and rapid growth 3 Top-tier client base and strategic partnerships with ©) Philips and Siemens Healthineers | | e ‘a C | C
Slide 20: Table of contents
Table of contents smentice o o Market overview and the medical challenges we are helping solve @ I 4) Status update of QI 2022 “ |
Slide 21: Order Intake & Order Book Q1 2022
Order Intake & Order Book QI 2022 Order intake at 54.4m — growth 36.3% » Welcomed comeback from Healthcare Systems * Consistent performance from Medical Device Industry * Strong Ql for Strategic Alliances thanks to Corindus China order Order intake per Orderbook at 91.4m — growth 25% * Systems 16.7m
Slide 22: Order Intake: Long-Term Overview
Order Intake: Long-Term Overview «mentice rrr » Mentice has been growing at a . high pace during the last 10 years 160 with a order intake of CAGR of about 17% during 2012-2022 Ql, ro despite difficult period 2019-2021 5° 0 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 . . —Tot —Mdi * Mentice’s
Slide 23: Business Areas: Net Sales and growth Q1 2022
Business Areas: Net Sales and growth QI 2022 Medical Device Industry Healthcare Systems Strategic Alliances * Global providers of MedTech devices. The business area includes solutions for training, sales and marketing, research and clinical evaluation. Overarching objectives is to assist our Clients
Slide 24: Q1 22 growth by business area
Q122 +40% YoY +298% YoY -1% YoY
Slide 25: Business Segments (IFRS 8): Net sales Q1 2022
Business Segments (IFRS 8): Net sales QI 2022 simentice Mentice is gradually shifting its revenue from capital expenditure to operational expenditures RECURRING REVENUE ROLLING FOUR QUARTERS (MSEK) * Recurring revenue grew 108% YoY in quarter 1 a0 2022, both from subscription of software and rental
Slide 26: Financial update – Q1 2022
Financial update — QI] 2022 #mentice Income Statement (SEKm) Q12022 Q12021 * Gross margin for QI'22 amounted to 80.1% (80.3%) which is similar Net sales 53.1 32.3 to the level last year for the same quarter, an increase of 17m in gross Other income 16 12 profit in 2022. sales 547 33.5 . cocs -105 6.
Slide 27: Business summary
Business summary # mentice Mentice’s business during Q1 2022 represent another quarter of growth with a welcomed comeback for the hospital related business, coupled with a consistent business from the medical device industry. From an order intake perspective this quarter is the strongest Q1 in Menti
Slide 28: -mentice
-mentice Goran Malmberg CEO and Group President +46 703 09 22 22 goran.malmberg@mentice.com Gunilla Andersson Group CFO +46 702 13 71 38 gunilla.andersson@mentice.com